Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1489-1493

  Ghazanfari, Tooba ^a   Sharifnia, Zarin ^a   Yaraee, Roya ^a   Pourfarzam, Shahryar ^a   Kariminia, Amina ^b   Mahlojirad, Maryam ^a,c   Faghihzadeh, Soghrat ^d   Jalali Nodoushan, Mohammad Reza ^a   Ardestani, Sussan K ^e   Soroush, Mohammad R ^f   Amiri, Sara ^a   Hassan, Zuhair M ^d   Ghavami, Saeid ^g   Ghanei, Mostafa ^h  

^a SHAHED UNIVERSITY   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

^f JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^g UNIVERSITY OF MANITOBA   (Canada)

^h BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fas ligand; Inflammation; Iran; Mustard gas; Nitric oxide; Pulmonary

Indexed keywords

FAS LIGAND; MUSTARD GAS; NITRIC OXIDE;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; IRAN; LEUKOCYTE COUNT; LONG TERM EXPOSURE; LUNG FUNCTION TEST; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CHEMICAL WARFARE AGENTS; COHORT STUDIES; DISEASE PROGRESSION; FAS LIGAND PROTEIN; HUMANS; IRAN; MUSTARD GAS; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 70350564963     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.019     Document Type: Article

References (32)

1. Ghazanfari T., Faghihzadeh S., Aragizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran cohort study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (2009) 5-14
2. Jalali Nadoushan M.R., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Moaiedmohseni S., et al. Total serum bilirubinemia and intensity of sulfur mustard exposure in Iranian chemical victims 20 years after exposure. Toxin Rev 28 1 (2009) 44-47
3. Ghasemi H., Ghazanfari T., Yaraee R., Soroush M.R., Ghassemi-Broumand M., Pourfarzam Sh., et al. Systemic and ocular complications of sulfur mustard: a panoramic review. Toxin Rev 28 1 (2009) 14-23
4. Moin A., Ghazanfari T., Davoudi S.M., Emadi N., Panahi Y., Hassan Z.M., et al. Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran. Toxin Rev 28 1 (2009) 24-29
5. Khateri S., Ghanei M., Keshavarz S., Soroush M., and Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 11 (2003) 1136-1143
6. Pourfarzam Sh., Ghazanfari T., Merasizadeh J., Ghanei M., Azimi G., Araghizadeh H., et al. Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Rev 28 1 (2009) 8-13
7. Emad A., and Emad Y. Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol 28 4 (Jul 2008) 298-305
8. Ghanei M., Adibi I., Farhat F., and Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?. Chron Respir Dis 5 2 (2008) 95-100
9. Janssen O., Qian J., Linkermann A., and Kabelitz D. CD95 ligand-death factor and costimulatory molecule?. Cell Death Differ 10 11 (2003) 1215-1225
10. Martin T.R., Nakamura M., and Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 31 4 Suppl (Apr 2003) S184-S188
11. I.K. Demedts, T. Demoor, K.R. Bracke, G.F. Joos, G.G. Brusselle. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 30;7:53.
12. Dosreis G.A., Borges V.M., and Zin W.A. The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8 3 (2004) 285-293
13. Takabatake N., Nakamura H., Inoue S., Terashita K., Yuki H., Kato S., et al. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. Respir Med 94 12 (2000) 1215-1220
14. Ricciardolo F.L. Multiple roles of nitric oxide in the airways. Thorax 58 2 (2003) 175-182
15. Ricciardolo F.L., Sterk P.J., Gaston B., and Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84 3 (2004) 731-765
16. Hesslinger C., Strub A., Boer R., Ulrich W.R., Lehner M.D., and Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 37 Pt 4 (2009) 886-891
17. Ricciardolo F.L., Nijkamp F.P., and Folkerts G. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets 7 6 (2006) 721-735
18. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 152 3 (1995) 1107-1136
19. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
20. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
21. Ghanei M., and Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19 5 (2007) 451-456
22. Yasuda N., Gotoh K., Minatoguchi S., Asano K., Nishigaki K., Nomura M., et al. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 92 8 (1998) 993-999
23. Ghanei M., Tazelaar H.D., Chilosi M., Harandi A.A., Peyman M., Akbari H.M., et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102 (2008) 825-830
24. Ghanei M., Eshraghi M., Peyman M., Alaeddini F., Jalali A.R., and Sajadi V. Pulmonary function test trend in adult bronchiolitis obliterans. Tanaffos 6 (2007) 40-46
25. Hodge S.J., Hodge G.L., Reynolds P.N., Scicchitano R., and Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 285 (2003) 492-499
26. Aghanouri R., Ghanei M., Aslani J., Keivani-Amine H., and Rastegar Fand Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287 (2004) L1160-L1164
27. Askenasy N., Yulco E.S., Yaniv I., and Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulat. Blood 105 (2005) 1396-1404
28. Brune B., von Knethen A., and Sandau K.B. Nitric oxide and its role in apoptosis. Eur J Pharmacol 351 (1998) 261-272
29. Kim P.K.M., Zamora R., Petrosko P., and Billiar T.R. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 1 (2001) 1421-1441
30. Dash P.R., McCormick J., Thomson M.J., Johnstone A.P., Cartwright J.E., and Whitley G.S. Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon. Exp Cell Res 313 16 (2007) 3421-3431
31. Beheshti J., Mark E.J., Akbaei H.M., Aslani J., and Ghanei M. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202 10 (2006) 739-744
32. Shams J., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Hassan Z.M., et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 28 1 (2009) 39-43